ArticleACS medicinal chemistry letters2022

Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action.

Michael Lückmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.